Singular Genomics Systems Inc (NAS:OMIC)
$ 0.348 0.0052 (1.52%) Market Cap: 25.78 Mil Enterprise Value: -51.80 Mil PE Ratio: 0 PB Ratio: 0.16 GF Score: 32/100

Singular Genomics Systems Inc at JPMorgan Healthcare Conference Transcript

Jan 12, 2023 / 06:30PM GMT
Release Date Price: $2.01 (+2.03%)
Unidentified Analyst

Good morning, everyone. My name is Marta [Lazarus]. I'm from the Growth Lifescience Tools and Diagnostics team. Welcome to the last day of JPMorgan Health Conference. And it's my pleasure to introduce our next company, Singular Genomics.

As a reminder, we'll have a Q&A after the presentation. So if you want to ask a question, you can raise your hand or enter it online. And with that, I will turn it over to the management team.

Dalen Meeter
Singular Genomics Systems, Inc. - Senior VP of Finance & CFO

Thank you, Marta. Thank you to the JPMorgan team for the opportunity to present here at the conference today. My name is Dalen Meeter. I'm the Chief Financial Officer of Singular Genomics. Presenting with me today is Eli Glezer, our Chief Science Officer and Co-Founder. We posted an updated investor deck on our website. I'd encourage everybody to please download that. Please note that the usual forward-looking statements, disclaimer applies for today's presentation.

We'll touch on 4 key themes today: number one, the G4 is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot